Expression of exogenous tissue factor pathway inhibitor in vivo suppresses thrombus formation in injured rabbit carotid arteries

Journal of the American College of Cardiology

Volumn 38, Issue 2, 2001, Pages 569-576

  Golino, Paolo ^a   Cirillo, Plinio ^a   Calabro, Paolo ^a   Ragni, Massimo ^a   D'Andrea, Davide ^a   Avvedimento, Enrico V ^b   Vigorito, Francesco ^a   Corcione, Nicola ^a   Loffredo, Francesco ^a   Chiariello, Massimo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; TETRACYCLINE; TISSUE FACTOR PATHWAY INHIBITOR; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY WALL; ARTICLE; CAROTID ARTERY INJURY; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; GENE TRANSFER; IN VIVO STUDY; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; RABBIT; REPORTER GENE; RETROVIRUS; THROMBOGENESIS; THROMBOSIS; VIRUS RECOMBINANT;

ANIMALS; ANTICOAGULANTS; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CAROTID ARTERY THROMBOSIS; CELLS, CULTURED; GENE THERAPY; GENETIC VECTORS; IMMUNOHISTOCHEMISTRY; LIPOPROTEINS; MUSCLE, SMOOTH, VASCULAR; RABBITS; RECOMBINANT FUSION PROTEINS; RETROVIRIDAE; TRANSFECTION;

EID: 0034883965     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01350-X     Document Type: Article

References (35)

1. Acute coronary syndromes: Pathophysiology and preventive priorities
2. Specific platelet mediators and unstable coronary artery lesions
3. Tissue factor and hemostasis
4. A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries
5. A monoclonal antibody against tissue factor shortens tissue-plasminogen activator lysis rime and prevents reocclusion in a rabbit model of carotid artery thrombosis
6. Antithrombotic effects of recombinant human, active site-blocked factor VIIa in a rabbit model of recurrent arterial thrombosis
7. Localization of tissue factor in the normal vessel wall and in the atherosderotic plaque
8. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes
9. Tissue factor antigen and activity in human coronary atherosclerotic plaques
10. TFPI and the revised theory of coagulation
11. The lipoproteinassociated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: Insight into its possible mechanism of action
12. Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated coagulation inhibitor
13. Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model
14. Inhibition of tissue factor-mediated coagulation markedly attenuates stenosis after balloon-induced arterial injury in minipigs
15. Recombinant gene expression in vivo within the endothelial cells of the arterial wall
16. Implantation of vascular grafts lined with genetically modified endothelial cells
17. Cardiovascular gene therapy
18. A simple method for the isolation, cultivation, and characterization of endothelial cells from rabbit coronary circulation
19. Single-step method of RNA isolation by acid guanidinium thiocynate-phenol-chloroform extraction
20. Tight control of gene expression in mammalian cells by tetracycline responsive promoters
21. Production of high-titer helper-free retroviruses by transient transfection
22. Activated platelets and leucocytes cooperatively stimulate smooth muscle cell proliferation and protooncogene expression via release of soluble growth factors
23. Experimental carotid stenosis and endothelial injury in the rabbit: An in vivo model to study intravascular platelet aggregation
24. Platelet aggregation in partially obstructed vessels and its elimination by aspirin
25. Expression of tissue factor pathway inhibitor in vascular smooth muscle cells and its regulation by growth factors
26. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques
27. Endogenous tissue factor pathway inhibitor modulates thrombus formation in an in vivo model of rabbit carotid artery stenosis and endothelial injury
28. Bleeding complications with new antithrombotics used in ischemic heart disease
29. Local adenoviral-mediated expression of recombinant hirudin reduces neointima formation after arterial injury
30. Prevention of arterial thrombosis by adenovirus-mediated transfer of cyclooxygenase gene
31. Enhanced in vivo antithrombotic effects of endothelial cells expressing recombinant plasminogen activators transduced with retroviral vectors
32. Overexpression of human endothelial nitric oxide synthase in rat vascular smooth muscle cells and in balloon-injured carotid artery
33. Local overexpression of thrombomodulin for in vivo prevention of arterial thrombosis in a rabbit model
34. Adenovirus-mediated local expression of human tissue factor pathway inhibitor eliminates shear stress-induced recurrent thrombosis in the injured carotid artery of the rabbit
35. Thromboresistance of balloon-injured porcine carotid arteries after local gene transfer of human tissue factor pathway inhibitor